GenDx
Specialized in molecular transplant diagnostics, GenDx, part of Eurobio Scientific Group, develops and offers a comprehensive line of reagents and services, analysis software, and education.
Our history
Board of Directors
Per October 4, 2022, the Paris, France-based Eurobio Scientific (“Eurobio”) acquired all outstanding shares of GenDx (also known as Genome Diagnostics) as was publicly announced after signing the Share Purchase Agreement on 17 August. The board of director currently consists of Maarten Penning PhD (executive director), Denis Fortier and Hervé Duchesne de Lamotte (non-executive directors).
Founders
In 2005, Erik Rozemuller PhD and Wietse Mulder PhD co-founded GenDx. Erik Rozemuller brought extensive experience in bioinformatics, particularly in software development in the field of genetics of polymorphism and mutations. Wietse Mulder has ample experience in both scientific research as well in the commercialization of both products and custom research services. Together, they were committed to a singular mission throughout their 20-year journey: “To improve the quality of life and survival of transplant patients”. Based on their motivation and inspiration, they fostered GenDx’s growth into a global player in transplant diagnostics. In 2023, they stepped down from their formal roles at GenDx, but they remain motivated to support the field of stem cell and solid organ transplantation.
Our Mission & Vision
Mission
Improve the quality of life and survival of transplant patients
Vision
Advance the field of transplantation by offering excellent molecular diagnostic tools and sharing knowledge
Our Values
Leadership
- We aim to be a global leader in molecular diagnostics
Commitment
- We improve the quality of life of transplant patients by delivering excellent diagnostic tools.
- We put our customers first.
- We believe in the success of long-term development of our partnerships.
- We value our employees and encourage their professional growth
Sharing
- We strongly believe that it is crucial to share knowledge and experience with partners.
- We have a strong focus on excellent customer support, education and collaboration.
Independence
- We believe that an independent position is a prerequisite for meaningful growth in our field of business
Company Info
Genome Diagnostics B.V.
Trade name: GenDx
Yalelaan 48, 3584 CM, Utrecht, The Netherlands
E info@gendx.com | T +31 (0)30 252 3799
DUNS number: 413493037 | Chamber of Commerce: 30202468 | VAT: NL814323194B01
Bank account details
Rabobank
Account number: NL73 RABO 0311 3449 76
IBAN: NL73 RABO 03113 449 76
Bank identifier Code: RABONL2U
ABN Amro
Account number: NL65 ABNA 0847 1390 93
IBAN: NL65 ABNA 0847 1390 93
Bank identifier Code: ABNANL2A
Genome Products B.V.
Trade name: GenDx Products
Yalelaan 48, 3584 CM, Utrecht, The Netherlands
E info@gendx.com | T +31 (0)30 252 3799
DUNS number: 413588208 | Chamber of Commerce: 30203002 | VAT: NL814323145B01
Bank account details
Rabobank
Account number: NL73 RABO 0311 3449 33
IBAN: NL73 RABO 03113 449 33
Bank identifier Code: RABONL2U
ABN Amro
Account number: NL60 ABNA 0847 1321 02
IBAN: NL60 ABNA 0847 1321 02
Bank identifier Code: ABNANL2A
GenDx Products Inc.
Cumberland Metro Office Park
5521 N. Cumberland Avenue
Suite 1116
Chicago, IL 60656
E info@gendx.org | T +1 (312) 815 5006
| Business registration Pennsylvania | 4233043 |
| Business registration Maryland | F16964777 |
| DUNS Number | 079288107 |
| EIN | 46-4533412 |
| Wells Fargo checking account | 3809428687 |
| Wire Routing: | 121000248 |
| Bank Identifier Code (SWIFT) | WFBIUS6S |
